# Atypical Parathyroid Tumor Causing Primary Hyperparathyroidism With a Clinical Presentation of a Brown Tumor

**Authors:** Nathanaël Saison, Sandra Fatio, Dominik Pytlik, Stephan Rauthe, Roger Schmid, Chantal Stutz

PMC · DOI: 10.1210/jcemcr/luaf154 · JCEM Case Reports · 2025-07-11

## TL;DR

A rare atypical parathyroid tumor caused primary hyperparathyroidism and a brown tumor in a patient with a complex medical history.

## Contribution

This case report highlights the rare association between atypical parathyroid tumors and brown tumors.

## Key findings

- Atypical parathyroid tumors can lead to brown tumors in rare cases.
- A multidisciplinary approach is essential for diagnosing and managing these rare conditions.
- Long-term surveillance is important for atypical parathyroid tumors due to potential malignancy risks.

## Abstract

Brown tumors are rare osteolytic bone lesions linked to primary hyperparathyroidism (pHPT), caused by excessive parathyroid hormone (PTH) production. They feature microfractures, hemorrhage, and hemosiderin deposition. Atypical parathyroid tumors (APT) are uncommon parathyroid neoplasms with histologic features resembling carcinoma but without definitive parathyroid carcinoma (PC) criteria. APTs can rarely lead to brown tumors. We report a 53-year-old male with a history of nephrectomy for renal cell carcinoma and Hodgkin disease. Imaging revealed a growing osteolytic lesion in the left iliac bone. Laboratory findings indicated pHPT with elevated PTH levels. Sonography and 18F-fluorocholine positron emission tomography–computed tomography (PET-CT) identified a right inferior parathyroid tumor. The patient underwent focused parathyroidectomy, and histology confirmed APT with fibrous tracts and trabecular growth features. APT accounts for 0.5% to 4.4% of parathyroid surgeries and may rarely lead to brown tumors. Differentiating brown tumors from malignancies requires biochemical, imaging, and histopathological evaluation. Although APTs generally follow a benign course, long-term surveillance is essential, particularly in familial cases. Further research is needed to investigate the malignancy potential and recurrence risk of rare atypical parathyroid neoplasms. This case highlights the importance of a multidisciplinary approach in their diagnosis and management.

## Linked entities

- **Chemicals:** 18F-fluorocholine (PubChem CID 404592)
- **Diseases:** primary hyperparathyroidism (MONDO:0010837), renal cell carcinoma (MONDO:0005086), Hodgkin disease (MONDO:0004952)

## Full-text entities

- **Genes:** PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}
- **Diseases:** Hodgkin disease (MESH:D006689), osteolytic bone lesions (MESH:D001847), APT (MESH:D010282), Primary Hyperparathyroidism (MESH:D049950), renal cell carcinoma (MESH:D002292), hemorrhage (MESH:D006470), Brown Tumor (MESH:D009369), osteolytic lesion (MESH:D030981)
- **Chemicals:** 18F-fluorocholine (MESH:C514960)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12246681/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12246681/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12246681/full.md

---
Source: https://tomesphere.com/paper/PMC12246681